Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells.

Coelho dos Santos JS, Menezes CA, Villani FN, Magalhães LM, Scharfstein J, Gollob KJ, Dutra WO.

Clin Exp Immunol. 2010 Dec;162(3):528-36. doi: 10.1111/j.1365-2249.2010.04270.x. Epub 2010 Oct 21.

2.

Infection-associated vasculopathy in experimental chagas disease pathogenic roles of endothelin and kinin pathways.

Scharfstein J, Andrade D.

Adv Parasitol. 2011;76:101-27. doi: 10.1016/B978-0-12-385895-5.00005-0. Review.

PMID:
21884889
3.

Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.

Scharfstein J, Schmitz V, Morandi V, Capella MM, Lima AP, Morrot A, Juliano L, Müller-Esterl W.

J Exp Med. 2000 Nov 6;192(9):1289-300.

4.

Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection.

de Souza SM, Vieira PM, Roatt BM, Reis LE, da Silva Fonseca K, Nogueira NC, Reis AB, Tafuri WL, Carneiro CM.

Mol Immunol. 2014 Mar;58(1):92-7. doi: 10.1016/j.molimm.2013.11.007. Epub 2013 Dec 7.

PMID:
24317279
5.

Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.

Argüello RJ, Albareda MC, Alvarez MG, Bertocchi G, Armenti AH, Vigliano C, Meckert PC, Tarleton RL, Laucella SA.

PLoS One. 2012;7(5):e35966. doi: 10.1371/journal.pone.0035966. Epub 2012 May 4.

6.

Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.

Monteiro AC, Schmitz V, Svensjo E, Gazzinelli RT, Almeida IC, Todorov A, de Arruda LB, Torrecilhas AC, Pesquero JB, Morrot A, Bouskela E, Bonomo A, Lima AP, Müller-Esterl W, Scharfstein J.

J Immunol. 2006 Nov 1;177(9):6325-35.

7.
8.

Apoptotic CD8 T-lymphocytes disable macrophage-mediated immunity to Trypanosoma cruzi infection.

Cabral-Piccin MP, Guillermo LV, Vellozo NS, Filardy AA, Pereira-Marques ST, Rigoni TS, Pereira-Manfro WF, DosReis GA, Lopes MF.

Cell Death Dis. 2016 May 19;7:e2232. doi: 10.1038/cddis.2016.135.

9.

Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.

Pérez-Antón E, Egui A, Thomas MC, Puerta CJ, González JM, Cuéllar A, Segovia M, López MC.

PLoS Negl Trop Dis. 2018 May 11;12(5):e0006480. doi: 10.1371/journal.pntd.0006480. eCollection 2018 May.

10.

Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, Alvarez-Leite JI, Ropert C, Gazzinelli RT.

J Immunol. 2004 Feb 1;172(3):1711-8.

11.
12.

Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes.

Todorov AG, Andrade D, Pesquero JB, Araujo Rde C, Bader M, Stewart J, Gera L, Müller-Esterl W, Morandi V, Goldenberg RC, Neto HC, Scharfstein J.

FASEB J. 2003 Jan;17(1):73-5. Epub 2002 Nov 1.

PMID:
12424228
13.

Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infection.

Sanoja C, Carbajosa S, Fresno M, Gironès N.

PLoS One. 2013 Jun 11;8(6):e65820. doi: 10.1371/journal.pone.0065820. Print 2013.

14.

Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice.

Santamaría MH, Corral RS.

Cytokine. 2013 Feb;61(2):491-8. doi: 10.1016/j.cyto.2012.10.027. Epub 2012 Nov 28.

PMID:
23199812
15.
16.

Cynomolgus macaques naturally infected with Trypanosoma cruzi-I exhibit an overall mixed pro-inflammatory/modulated cytokine signature characteristic of human Chagas disease.

Vitelli-Avelar DM, Sathler-Avelar R, Mattoso-Barbosa AM, Gouin N, Perdigão-de-Oliveira M, Valério-Dos-Reis L, Costa RP, Elói-Santos SM, Gomes MS, Amaral LR, Teixeira-Carvalho A, Martins-Filho OA, Dick EJ Jr, Hubbard GB, VandeBerg JF, VandeBerg JL.

PLoS Negl Trop Dis. 2017 Feb 22;11(2):e0005233. doi: 10.1371/journal.pntd.0005233. eCollection 2017 Feb.

17.

Inflammatory mediators from monocytes down-regulate cellular proliferation and enhance cytokines production in patients with polar clinical forms of Chagas disease.

Gomes JA, Molica AM, Keesen TS, Morato MJ, de Araujo FF, Fares RC, Fiuza JA, Chaves AT, Pinheiro V, Nunes Mdo C, Correa-Oliveira R, da Costa Rocha MO.

Hum Immunol. 2014 Jan;75(1):20-8. doi: 10.1016/j.humimm.2013.09.009. Epub 2013 Sep 24.

PMID:
24071371
18.

Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.

Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, James MA.

Am J Trop Med Hyg. 1998 Jan;58(1):119-21.

PMID:
9452302
19.

Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.

Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.

Cell Immunol. 1996 May 25;170(1):41-53.

PMID:
8660798
20.

Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.

Lopes MF, Nunes MP, Henriques-Pons A, Giese N, Morse HC 3rd, Davidson WF, Araújo-Jorge TC, DosReis GA.

Eur J Immunol. 1999 Jan;29(1):81-9.

Supplemental Content

Support Center